Royalty Pharma Plc (RPRX) Institutional Shareholders
Royalty Pharma Plc (RPRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $20.29B in RPRX holdings during the latest filing period.
Morgan Stanley is currently the largest disclosed institutional shareholder of RPRX tracked by InsiderSet, reporting ownership valued at approximately $2.41B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.53B, representing an estimated gain of +5.10% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 53% of the total disclosed RPRX value among the investors covered in this analysis. Major shareholders include Morgan Stanley, Capital International Investors, Blackrock, Inc., and several other long-term asset managers with concentrated positions in Royalty Pharma Plc (RPRX).
This page ranks the largest institutional RPRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
629
Total Reported Value
$20.29B
Largest Holder
Morgan Stanley
Largest Position
$2.41B
Insider Transactions (90d)
17
Latest Filing Quarter
Q2 2026
New Institutional Positions
53
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 0.13% | 42,931,597 | $2,407,174,722 | $2,529,959,011 | +$122,784,289 | +5.10% | |
| Capital International Investors | 0.41% | 35,273,770 | $1,977,800,284 | $2,078,683,266 | +$100,882,982 | +5.10% | |
| Blackrock, Inc. | 0.02% | 27,832,977 | $1,560,595,060 | $1,640,197,335 | +$79,602,275 | +5.10% | |
| Fmr Llc | 0.06% | 24,513,814 | $1,374,489,542 | $1,444,599,059 | +$70,109,517 | +5.10% | |
| State Street Corp | 0.02% | 12,338,229 | $691,804,500 | $727,091,835 | +$35,287,335 | +5.10% | |
| Price T Rowe Associates Inc | 0.06% | 11,193,657 | $627,629,000 | $659,642,207 | +$32,013,207 | +5.10% | |
| Swedbank Ab | 0.52% | 10,726,608 | $601,440,912 | $632,119,009 | +$30,678,097 | +5.10% | |
| Baillie Gifford & Co | 0.51% | 10,015,578 | $561,573,459 | $590,218,012 | +$28,644,553 | +5.10% | |
| Capital World Investors | 0.06% | 9,517,337 | $533,637,086 | $560,856,669 | +$27,219,583 | +5.10% | |
| Geode Capital Management, Llc | 0.02% | 8,058,048 | $450,581,226 | $474,860,769 | +$24,279,543 | +5.39% | |
| Caledonia (Private) Investments Pty Ltd | 11.06% | 5,775,851 | $323,851,966 | $340,370,899 | +$16,518,933 | +5.10% | |
| Norges Bank | 0.03% | 5,336,084 | $299,194,230 | $314,455,430 | +$15,261,200 | +5.10% | |
| Vanguard Capital Management Llc | 0.01% | 4,826,617 | $270,628,415 | $284,432,540 | +$13,804,125 | +5.10% | |
| Northern Trust Corp | 0.03% | 4,718,859 | $264,586,425 | $278,082,361 | +$13,495,936 | +5.10% | |
| Royal London Asset Management Ltd | 0.45% | 4,319,595 | $242,199,693 | $254,553,733 | +$12,354,040 | +5.10% | |
| Aqr Capital Management Llc | 0.08% | 4,305,412 | $241,404,423 | $253,717,929 | +$12,313,506 | +5.10% | |
| Invesco Ltd. | 0.02% | 4,232,577 | $237,320,598 | $249,425,763 | +$12,105,165 | +5.10% | |
| Bank Of America Corp | 0.01% | 4,149,422 | $232,658,117 | $244,525,438 | +$11,867,321 | +5.10% | |
| Legal & General Group Plc | 0.04% | 3,800,504 | $213,094,266 | $223,963,701 | +$10,869,435 | +5.10% | |
| Victory Capital Management Inc | 0.12% | 3,682,932 | $206,501,997 | $217,035,183 | +$10,533,186 | +5.10% | |
| Patient Capital Management, Llc | 6.70% | 3,598,808 | $201,785,166 | $212,077,755 | +$10,292,589 | +5.10% | |
| Ubs Group Ag | 0.03% | 3,143,347 | $176,247,466 | $185,237,439 | +$8,989,973 | +5.10% | |
| Charles Schwab Investment Management Inc | 0.02% | 3,083,528 | $172,893,415 | $181,712,305 | +$8,818,890 | +5.10% | |
| Two Sigma Investments, Lp | 0.12% | 2,920,163 | $163,733,539 | $172,085,206 | +$8,351,667 | +5.10% | |
| Deutsche Bank Ag\ | 0.04% | 2,717,951 | $152,395,512 | $160,168,852 | +$7,773,340 | +5.10% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.03% | 3,095,766 | $148,503,894 | $182,433,490 | +$33,929,596 | +22.85% | |
| Nordea Investment Management Ab | 0.12% | 2,576,772 | $146,154,507 | $151,849,174 | +$5,694,667 | +3.90% | |
| Adage Capital Partners Gp, L.L.C. | 0.20% | 2,500,000 | $140,175,000 | $147,325,000 | +$7,150,000 | +5.10% | |
| Vanguard Portfolio Management Llc | 0.01% | 2,459,990 | $137,931,639 | $144,967,211 | +$7,035,572 | +5.10% | |
| Dorsey Asset Management | Pat Dorsey | 8.82% | 2,456,528 | $137,737,525 | $144,763,195 | +$7,025,670 | +5.10% |
| Marshall Wace, Llp | 0.12% | 2,450,669 | $137,409,011 | $144,417,924 | +$7,008,913 | +5.10% | |
| Regal Partners Ltd | 7.58% | 2,447,879 | $137,252,575 | $144,253,509 | +$7,000,934 | +5.10% | |
| Arrowstreet Capital, Limited Partnership | 0.06% | 2,435,341 | $136,549,570 | $143,514,645 | +$6,965,075 | +5.10% | |
| Goldman Sachs Group Inc | 0.01% | 2,416,331 | $135,483,683 | $142,394,386 | +$6,910,703 | +5.10% | |
| New South Capital Management Inc | 5.87% | 2,385,943 | $133,779,824 | $140,603,621 | +$6,823,797 | +5.10% | |
| Vanguard Fiduciary Trust Co | 0.03% | 2,163,271 | $121,294,605 | $127,481,560 | +$6,186,955 | +5.10% | |
| Renaissance Technologies LLC | Jim Simons | 0.15% | 1,935,800 | $108,540,306 | $114,076,694 | +$5,536,388 | +5.10% |
| Jpmorgan Chase & Co | 0.01% | 1,755,826 | $100,240,158 | $103,470,826 | +$3,230,668 | +3.22% | |
| Russell Investments Group, Ltd. | 0.08% | 1,694,250 | $95,556,830 | $99,842,153 | +$4,285,323 | +4.48% | |
| Clark Capital Management Group, Inc. | 0.51% | 1,663,003 | $93,244,586 | $98,000,767 | +$4,756,181 | +5.10% | |
| Homestead Advisers Corp | 2.31% | 1,657,242 | $92,921,559 | $97,661,271 | +$4,739,712 | +5.10% | |
| Raymond James Financial Inc | 0.02% | 1,599,881 | $89,705,357 | $94,280,987 | +$4,575,630 | +5.10% | |
| Qube Research & Technologies Ltd | 0.09% | 1,412,112 | $79,177,120 | $83,215,760 | +$4,038,640 | +5.10% | |
| Eventide Asset Management, Llc | 1.04% | 1,380,261 | $77,668,505 | $81,338,781 | +$3,670,276 | +4.73% | |
| Citadel Advisors Llc | 0.04% | 1,354,640 | $75,954,665 | $79,828,935 | +$3,874,270 | +5.10% | |
| Bank Of New York Mellon Corp | 0.01% | 1,268,918 | $71,148,210 | $74,777,338 | +$3,629,128 | +5.10% | |
| Hsbc Holdings Plc | 0.03% | 1,224,925 | $68,770,130 | $72,184,830 | +$3,414,700 | +4.97% | |
| Bnp Paribas Asset Management Holding S.A. | 0.07% | 1,203,706 | $67,557,956 | $70,934,395 | +$3,376,439 | +5.00% | |
| Sumitomo Mitsui Trust Group, Inc. | 0.04% | 1,187,943 | $66,607,964 | $70,005,481 | +$3,397,517 | +5.10% | |
| Swiss National Bank | 0.03% | 1,159,800 | $65,029,986 | $68,347,014 | +$3,317,028 | +5.10% |
Frequently asked questions about RPRX
Who owns the most RPRX stock?
The largest holders of RPRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for Royalty Pharma Plc (RPRX).
Is RPRX widely held by superinvestors?
Many widely followed stocks like RPRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly RPRX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.